688266 泽璟制药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产444,208130.66%192,580205,30198,289109,214
在建工程64,901-76.48%275,930123,471135,82786,673
无形资产24,458-20.04%30,58950,01169,27091,030
商誉0--0000
其他非流动资产30,70513.80%26,98249,93363,48589,639
564,2717.26%526,081428,715366,871376,556

流动资产
货币资金2,094,1353.10%2,031,1802,153,6792,109,641797,047
应收账款204,28135.09%151,223143,304101,14088,985
存货192,87311.32%173,267182,861110,85298,978
其他流动资产470,680438.33%87,43496,054198,703306,745
2,961,96921.24%2,443,1042,575,8992,520,3361,291,755

流动负债
短期借款674,864-31.77%989,051951,862795,165390,793
应付票据39,22474.57%22,46910,20800
应付帐款254,51714.81%221,694186,895137,735151,721
其他流动负债216,56011.21%194,726224,480202,282186,671
1,185,165-17.00%1,427,9401,373,4461,135,181729,186
流动资产净值1,776,80475.03%1,015,1641,202,4531,385,155562,569
资产总额减流动负债2,341,07551.89%1,541,2461,631,1691,752,026939,126

非流动负债
长期借款83,500-0.60%84,00044,351050,094
应付债券0--0000
其他非流动负债537,08942.54%376,797334,217107,189101,545
620,58934.68%460,797378,568107,189151,639

总权益
    实收股本264,7080.00%264,708264,708264,708240,000
    储备项目1,455,77878.46%815,740989,1501,368,145519,118
股东权益1,720,48659.24%1,080,4481,253,8581,632,853759,118
非控股权益0--0(1,257)11,98428,368